E S Woodle

Summary

Affiliation: University of Chicago
Country: USA

Publications

  1. ncbi request reprint OKT3 escalating dose regimens provide effective therapy for renal allograft rejection
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Clin Transplant 10:389-95. 1996
  2. ncbi request reprint Liver transplantation in the first three months of life
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 66:606-9. 1998
  3. ncbi request reprint Programmed cell death
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 66:681-91. 1998
  4. ncbi request reprint Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection
    E S Woodle
    Department of Surgery, Committee on Immunology, Ben May Institute for Cancer Research, University of Chicago, Illinois 60637, USA
    Transplantation 68:608-16. 1999
  5. ncbi request reprint Outcomes of patients with rejection post-polyomavirus nephropathy
    J Trofe
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio, USA
    Transplant Proc 37:942-4. 2005
  6. ncbi request reprint Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity
    M Haas
    Departments of Pathology and Statistics, University of Chicago, Chicago, IL, USA
    Am J Kidney Dis 34:69-84. 1999
  7. ncbi request reprint Transplantation without steroids
    J W Alexander
    Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    Transplant Proc 34:2076-8. 2002
  8. ncbi request reprint Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy
    C C Rogers
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45267 0558, USA
    Transplant Proc 37:795-7. 2005
  9. doi request reprint Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss
    M J Everly
    Department of Surgery, Transplantation Division, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Am J Transplant 9:1063-71. 2009
  10. pmc Are concerns over right laparoscopic donor nephrectomy unwarranted?
    J F Buell
    Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA
    Ann Surg 233:645-51. 2001

Collaborators

Detail Information

Publications19

  1. ncbi request reprint OKT3 escalating dose regimens provide effective therapy for renal allograft rejection
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Clin Transplant 10:389-95. 1996
    ....
  2. ncbi request reprint Liver transplantation in the first three months of life
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 66:606-9. 1998
    ..Although infants in the first 3 months of life have not traditionally been considered a distinct age group, several features of these infants may distinguish them from other pediatric liver transplant recipients...
  3. ncbi request reprint Programmed cell death
    E S Woodle
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 66:681-91. 1998
    ..This Overview provides a definition of PCD, a description of known PCD biochemical pathways, and finally a discussion of the implications of PCD in transplantation...
  4. ncbi request reprint Phase I trial of a humanized, Fc receptor nonbinding OKT3 antibody, huOKT3gamma1(Ala-Ala) in the treatment of acute renal allograft rejection
    E S Woodle
    Department of Surgery, Committee on Immunology, Ben May Institute for Cancer Research, University of Chicago, Illinois 60637, USA
    Transplantation 68:608-16. 1999
    ..This report describes the results of a phase I trial of huOKT3gamma1(Ala-Ala) treatment of acute renal allograft rejection...
  5. ncbi request reprint Outcomes of patients with rejection post-polyomavirus nephropathy
    J Trofe
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio, USA
    Transplant Proc 37:942-4. 2005
    ..We sought to determine the effects of rejection in renal transplant recipients with polyomavirus nephropathy (PVN)...
  6. ncbi request reprint Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity
    M Haas
    Departments of Pathology and Statistics, University of Chicago, Chicago, IL, USA
    Am J Kidney Dis 34:69-84. 1999
    ....
  7. ncbi request reprint Transplantation without steroids
    J W Alexander
    Department of Surgery, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA
    Transplant Proc 34:2076-8. 2002
  8. ncbi request reprint Corticosteroid avoidance ameliorates lymphocele formation and wound healing complications associated with sirolimus therapy
    C C Rogers
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio 45267 0558, USA
    Transplant Proc 37:795-7. 2005
    ..To evaluate the possibility that RAPA and CS have additive effects on wound healing, we evaluated the effects of corticosteroid avoidance (CSAV) on wound healing complications in patients treated with RAPA...
  9. doi request reprint Reducing de novo donor-specific antibody levels during acute rejection diminishes renal allograft loss
    M J Everly
    Department of Surgery, Transplantation Division, University of Cincinnati College of Medicine, Cincinnati, OH, USA
    Am J Transplant 9:1063-71. 2009
    ..039). De novo DSAs detected at rejection are associated with reduced allograft survival, but prompt DSA reduction was associated with improved allograft survival. DSA should be considered a potential new end point for rejection therapy...
  10. pmc Are concerns over right laparoscopic donor nephrectomy unwarranted?
    J F Buell
    Department of Surgery, University of Cincinnati, Cincinnati, Ohio, USA
    Ann Surg 233:645-51. 2001
    ..To examine the ability of several large, experienced transplantation centers to perform right-sided laparoscopic donor nephrectomy safely with equivalent long-term renal allograft function...
  11. pmc Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients
    J M Millis
    Sections of Transplantation Surgery, University of Chicago, Chicago, Illinois 60637, USA
    Ann Surg 232:104-11. 2000
    ..To evaluate the impact of technical modifications on living-donor liver transplants in children since their introduction in 1989...
  12. ncbi request reprint The relationship of untreated borderline infiltrates by the Banff criteria to acute rejection in renal allograft biopsies
    S M Meehan
    Department of Pathology, University of Chicago, Illinois 60637, USA
    J Am Soc Nephrol 10:1806-14. 1999
    ....
  13. ncbi request reprint Transmission of donor cancer into cardiothoracic transplant recipients
    J F Buell
    Israel Penn International Transplant Tumor Registry, Department of Surgery, University of Cincinnati, Ohio 45267, USA
    Surgery 130:660-6; discussion 666-8. 2001
    ....
  14. doi request reprint Proteasome inhibitor therapy for antibody-mediated rejection
    E S Woodle
    Department of Surgery, University of Cincinnati, Cincinnati, OH, USA
    Pediatr Transplant 15:548-56. 2011
    ..These results demonstrate the significant potential of proteasome inhibition in addressing humoral barriers. However, the major advantage of proteasome inhibition lies in the numerous potential strategies for achieving synergy...
  15. ncbi request reprint Laparoscopic live donor nephrectomy: rationale, techniques, and implications
    S R Potter
    Department of Surgery, Division of Transplantation, University of Cincinnati, Cincinnati, Ohio, USA
    Semin Dial 14:365-72. 2001
    ..We review the development and refinement of LDN and its current rationale and applications...
  16. ncbi request reprint Ethical issues in increasing living kidney donations by expanding kidney paired exchange programs
    L F Ross
    Department of Pediatrics, MacLean Center for Clinical Medical Ethics, University of Chicago, Illinois 60637, USA
    Transplantation 69:1539-43. 2000
    ..In this article, we explore three variations that have potentially great clinical relevance...
  17. ncbi request reprint Polyomavirus in kidney and kidney-pancreas transplantation: a defined protocol for immunosuppression reduction and histologic monitoring
    Jennifer Trofe
    Department of Surgery, Division of Transplantation, The University of Cincinnati, 231 Albert Sabin Way, Cincinnati, OH 45267 0558, USA
    Transplant Proc 34:1788-9. 2002
  18. ncbi request reprint Corticosteroid elimination in renal transplantation: pro
    E S Woodle
    Department of Surgery, Division of Transplantation, University of Cincinnati, 231 Bethesday Avenue, PO Box 670558, Cincinnati, OH 45267, USA
    Transplant Proc 34:1693. 2002
  19. ncbi request reprint Programmed cell death signaling via cell-surface expression of a single-chain antibody transgene
    S Kulkarni
    Department of Surgery, University of Chicago, Illinois 60637, USA
    Transplantation 69:1209-17. 2000
    ..Immobilized 5H7 delivers programmed cell death (PCD) signals to human lymphoid tumor cells as well as peripheral blood mononuclear cells...